Members of Boulder-based Clovis Oncology Inc.’s board of directors are among the most highly compensated — at least on paper. But a single-day dive in the company’s stock from to $30 per share from $99 means they probably won’t be able to cash in. As of Thursday, the stock was trading at $13.82 per share. Clovis’ board members accounted for spots No.